Secukinumab efficacy and safety study in patients with active Rheumatoid Arthritis (RA) and an Inadequate response to anti-TNFα agents

Update Il y a 4 ans
Reference: EUCTR2011-006058-94

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Measure the proportion of subjects achieving an ACR20 response compared to placebo at week 24.


Inclusion criteria

  • Rheumatoid Arthritis